These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4610307)

  • 1. [Pharmaceutical view of rifampicin (author's transl)].
    Tsutsumi S; Sakamoto Y; Gido S
    Repura; 1974; 43(1):1-7. PubMed ID: 4610307
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical and biological properties of rifampicin.
    Furesz S
    Antibiot Chemother; 1970; 16():316-51. PubMed ID: 5002304
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin, a general review.
    Binda G; Domenichini E; Gottardi A; Orlandi B; Ortelli E; Pacini B; Fowst G
    Arzneimittelforschung; 1971 Dec; 21(12):1907-77. PubMed ID: 4945790
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampin: a semisynthetic derivative of rifamycin--a prototype for the future.
    Lester W
    Annu Rev Microbiol; 1972; 26():85-102. PubMed ID: 4562819
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin.
    Polascik M; Golden B
    Ann Ophthalmol; 1971 Aug; 3(8):877-82. PubMed ID: 5005929
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic effect of rifampicin (RFP) on leprosy. I. Clinical effect (observation of twelve months) (author's transl)].
    Repura; 1974; 43(1):8-25. PubMed ID: 4479678
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic effect of rifampicin (RFP) on leprosy. II. On the changes of the morphological index of M. leprae in patients (author's transl)].
    Ozawa T
    Repura; 1974; 43(1):26-34. PubMed ID: 4610308
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effect of rifampicin (RFP) on leprosy. IV. Serological examination (author's transl)].
    Abe M; Minagawa F; Yoshino Y
    Repura; 1974; 43(1):45-51. PubMed ID: 4479676
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effect of rifampicin (RFP) on leprosy. III. Histopathological investigation (author's transl)].
    Sasaki N; Kawatsu K
    Repura; 1974; 43(1):35-44. PubMed ID: 4479675
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of rifampicin to common infections (author's transl)].
    Nakagawa K; Watanabe K; Suzuki T
    Jpn J Antibiot; 1974 Apr; 27(2):69-72. PubMed ID: 4603394
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of rifampicin in the treatment of leprosy.
    Saerens EJ
    Lepr Rev; 1975 Jun; 46(2 Suppl):125-8. PubMed ID: 1100952
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlations between the biological properties and structure of rifampicin].
    Sensi P
    G Ital Mal Torace; 1969; ():Suppl 2:40-9. PubMed ID: 5357138
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical modifications and biological properties of rifamycins.
    Sensi P; Maggi N; Füresz S; Maffii G
    Antimicrob Agents Chemother (Bethesda); 1966; 6():699-714. PubMed ID: 4862170
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampicin.
    Drug Ther Bull; 1970 Jan; 8(3):11-2. PubMed ID: 5417897
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India.
    Lavania M; Nigam A; Turankar RP; Singh I; Gupta P; Kumar S; Sengupta U; John AS
    Clin Microbiol Infect; 2015 Dec; 21(12):e85-6. PubMed ID: 26314915
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of the binding of rifampicin to RNA polymerase.
    Lill UI; Hartmann GR
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1544. PubMed ID: 4567998
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of action of a rifamycin derivative (AF-013) which is active on the nucleic acid polymerases insensitive to rifampicin.
    Riva S; Fietta A; Silvestri LG
    Biochem Biophys Res Commun; 1972 Dec; 49(5):1263-71. PubMed ID: 4566674
    [No Abstract]   [Full Text] [Related]  

  • 18. Antituberculosis activity of rifampin. Report of studies performed and in progress (1966-1971).
    Nitti V
    Chest; 1972 Jun; 61(6):589-98. PubMed ID: 4624281
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chromosomal structure of Pseudomonas testosteroni. II. Activity of the endogenous RNA-polymerase (author's transl)].
    Reimer G; Drahovsky D
    Z Naturforsch C Biosci; 1976; 31(9-10):601-5. PubMed ID: 136130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the binding of rifampicin to the DNA-directed RNA polymerase from Escherichia coli.
    Lill UI; Hartmann GR
    Eur J Biochem; 1973 Oct; 38(2):336-45. PubMed ID: 4589980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.